Filtros de búsqueda

Lista de obras de Brian Durie

A clinical evaluation of indium-111 bleomycin as a tumor-imaging agent

artículo científico publicado en 1975

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival ⬇️

artículo científico publicado el 1 de septiembre de 1975

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

artículo científico publicado en 2019

A new basis for treatment of multiple myeloma

artículo científico publicado el 14 de octubre de 1978

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

artículo científico publicado en 2003

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

artículo científico publicado en 2007

A unique malignant T-cell lymphoproliferative disorder with neutropenia simulating hairy cell leukemia

artículo científico publicado en 1985

Acute myelogenous leukaemia modulated by B12 deficiency: a case with bone marrow blast cell assay corroboration.

artículo científico publicado en 1984

Acute promyelocytic leukemia

artículo científico publicado en 1987

Aggressive phase of multiple myeloma with pulmonary cell infiltrates

artículo científico publicado en 1982

Altered Polyamine Metabolism in Cystic Fibrosis

artículo científico publicado el 1 de octubre de 1979

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study ⬇️

artículo científico publicado el 1 de agosto de 1983

Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages

scientific article published on 01 December 1982

Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries

article

Analysis of multidrug‐resistance (MDR‐1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma ⬇️

artículo científico publicado el 1 de enero de 1993

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients

artículo científico publicado en 1985

Antibody specificity of the human monoclonal immunoglobulins: the elusive target antigen

artículo científico publicado en 1989

Antitumor activity of bovine cartilage extract (Catrix-S) in the human tumor stem cell assay

Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis

artículo científico publicado en 2020

Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients.

artículo científico publicado en 2011

Awareness, concern, and communication between physicians and patients on bone health in cancer

artículo científico publicado en 2014

Beta 2-microglobulin: a potentially useful marker for hematologic malignancies

artículo científico publicado el 1 de diciembre de 1981

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy

scientific article published on 01 December 2019

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

artículo científico publicado en 2005

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

artículo científico publicado en 2016

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

artículo científico publicado en 2020

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system ⬇️

artículo científico publicado el 1 de agosto de 1992

CALLA-positive myeloma: an aggressive subtype with poor survival

artículo científico publicado en 1985

Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.

artículo científico publicado en 2015

Cell kinetic analysis of human tumor stem cells

scientific article published on 01 January 1980

Cellular Kinetics, Staging, and Immunoglobulin Synthesis in Multiple Myeloma ⬇️

artículo científico publicado el 1 de enero de 1975

Cellular kinetics in multiple myeloma. A new approach to staging and treatment

artículo científico publicado el 1 de enero de 1975

Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.

artículo científico publicado en 1986

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC).

artículo científico

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

artículo científico publicado en 2016

Clarification of the definition of complete response in multiple myeloma

scientific article published on 21 October 2015

Clinical Staging and New Therapeutic Approaches in Multiple Myeloma ⬇️

artículo científico publicado el 1 de enero de 1978

Clinical correlations of drug sensitivity in the human tumor stem cell assay.

artículo científico

Clinical correlations of in vitro drug sensitivity

artículo científico

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)

artículo científico publicado en 2020

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

artículo científico publicado en 2018

Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study

artículo científico publicado en 2014

Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial

artículo científico publicado el 1 de enero de 1976

Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer ⬇️

artículo científico publicado el 1 de julio de 1975

Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma

artículo científico publicado en 1975

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

artículo científico publicado en 2012

Comparison of bone scintigraphy and radiography in multiple myeloma

artículo científico

Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma

scientific article published on 01 May 2008

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

artículo científico publicado en 2010

Connect MM Registry as a national reference for United States multiple myeloma patients

artículo científico publicado en 2019

Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics

artículo científico publicado en 2014

Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

artículo científico publicado en 2016

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

artículo científico publicado en 2015

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

artículo científico publicado en 2011

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

artículo científico publicado en 2011

Crossover confusion: MPT still best

scientific article published on 01 October 2008

Cystic fibrosis: decreased conjugation and excretion of [14C]spermidine

artículo científico publicado el 30 de junio de 1978

Danazol in hemophilia.

artículo científico publicado en 1984

Danazol in the treatment of myelodysplastic syndromes

artículo científico publicado en 1987

Danazol-induced factor VIII and IX bypassing activity in hemophiliacs

artículo científico publicado en 1985

Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma

scientific article published on 17 August 2020

Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features

artículo científico publicado en 1987

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma

scientific article published on 01 May 1999

Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

artículo científico publicado en 2018

Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry

artículo científico publicado en 2019

Discrimination between human T and B lymphocytes and monocytes by computer analysis of digitized data from scanning microphotometry. I. Chromatin distribution patterns ⬇️

artículo científico publicado el 1 de abril de 1978

Discrimination between human T and B lymphocytes by computer analysis of digitized data from scanning microphotometry. II. Discrimination and automated classification

artículo científico publicado el 1 de noviembre de 1978

Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse ⬇️

artículo científico publicado el 1 de mayo de 1976

Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine

artículo científico publicado en 1981

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

artículo científico publicado en 1989

ESAs not the culprit: more studies required

artículo científico publicado en 2008

Effect of Leukocyte Interferons on Cell Proliferation of Human Tumors In Vitro ⬇️

artículo científico publicado el 1 de enero de 1984

Effect of danazol on coagulation parameters and bleeding in hemophilia

artículo científico publicado en 1985

Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry

artículo científico publicado en 2020

Effects of cloned human leukocyte interferons in the human tumor stem cell assay

scientific article published on 01 March 1983

Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study.

artículo científico publicado en 2016

Efficacy of danazol in pure red cell aplasia

scientific article published on 01 December 1986

Eliminating the complete response penalty from myeloma response criteria

artículo científico publicado en 2008

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma

artículo científico publicado en 2017

Erratum: International uniform response criteria for multiple myeloma

scholarly article published in Leukemia

Erratum: International uniform response criteria for multiple myeloma

article

Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change

artículo científico publicado en 1985

Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas

artículo científico publicado en 1988

Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.

artículo científico publicado en 2009

Failure of indium 111-labeled bleomycin tumor scanning to predict response to bleomycin (NSC-125066) treatment

artículo científico publicado en 1974

Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an Example

artículo científico publicado en 2019

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

scholarly article by Ola Landgren et al published 19 November 2014 in American Journal of Hematology

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy

artículo científico publicado en 2007

Gene signature combinations improve prognostic stratification of multiple myeloma patients.

artículo científico publicado en 2015

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

artículo científico publicado en 2008

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

artículo científico publicado en 2011

Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma

artículo científico publicado en 2009

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

artículo científico publicado en 2008

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

artículo científico publicado en 2015

Health-Related Quality of Life (HRQoL) of Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM) Receiving Any or Lenalidomide (LEN) Maintenance After Autologous Stem Cell Transplant (ASCT) in the Connect® MM Disease Registry

artículo científico publicado en 2017

Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect® MM Disease Registry

artículo científico publicado en 2016

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)

artículo científico publicado en 2018

High Speed Scintillation Autoradiography ⬇️

artículo científico publicado el 12 de diciembre de 1975

High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia

artículo científico publicado en 1987

High-risk thyroid cancer. Prolonged survival with early multimodality therapy.

artículo científico publicado en 1981

Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration.

artículo científico publicado en 1983

IMWG consensus on maintenance therapy in multiple myeloma

artículo científico publicado en 2012

IMWG consensus on risk stratification in multiple myeloma

artículo científico

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

scientific article published on 08 June 2018

Immunologic Aspects of the Hematologic Neoplasms

artículo científico publicado en 1973

Immunoquantitation of free light chain immunoglobulins: Applications in multiple myeloma ⬇️

artículo científico publicado el 1 de enero de 1978

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

scientific article published on 01 July 2018

Impact of post-autologous stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the large prospective community-based Connect MM registry

artículo científico publicado en 2017

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

artículo científico publicado en 2018

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study

scientific article published on 01 August 1986

In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations

artículo científico publicado en 1982

Indium-111 bleomycin tumor scanning in lymphoma

artículo científico publicado en 1975

Interferons in the treatment of multiple myeloma

artículo científico publicado en 1990

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

artículo científico publicado en 2016

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation

artículo científico publicado en 2011

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

artículo científico publicado en 2016

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

artículo científico publicado en 2014

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

artículo científico publicado en 2008

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

artículo científico publicado en 2009

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

artículo científico publicado en 2009

International Myeloma Working Group recommendations for global myeloma care

artículo científico publicado en 2013

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

artículo científico publicado en 2013

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

artículo científico publicado en 2020

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

artículo científico publicado en 2014

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

scientific article published on 01 June 2019

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

artículo científico publicado en 2009

International staging system for multiple myeloma

artículo científico publicado en 2005

International uniform response criteria for multiple myeloma.

artículo científico publicado en 2006

Interrelationship between autoimmunity and B-lymphoid cell oncogenesis in humans

artículo científico

Kinetics of circulating B lymphocytes in human myeloma

artículo científico publicado en 1983

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232) ⬇️

artículo científico publicado el 27 de septiembre de 2010

Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma

artículo científico publicado en 1987

Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences

artículo científico publicado en 2010

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous

scientific article published on 11 May 2020

Low-dose thalidomide in myeloma: efficacy and biologic significance

artículo científico publicado en 2002

Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma

scientific article published on 16 April 2020

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods

scientific article published on 03 May 2017

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials

artículo científico publicado en 2004

Management of multiple myeloma in Asia: resource-stratified guidelines

artículo científico publicado en 2013

Management of multiple myeloma: a systematic review and critical appraisal of published studies ⬇️

artículo científico publicado el 1 de mayo de 2003

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

artículo científico

Management of treatment-emergent peripheral neuropathy in multiple myeloma.

artículo científico publicado en 2011

Meaningful endpoints for therapies approved for hematologic malignancies

artículo científico publicado en 2017

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

artículo científico publicado en 2010

Metabolism of [14C]spermidine and [14C]putrescine in normal volunteers and in cancer patients ⬇️

artículo científico publicado el 1 de octubre de 1978

Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

artículo científico publicado en 2009

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

artículo científico publicado el 1 de agosto de 1992

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives

artículo científico publicado en 2016

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

artículo científico publicado en 2010

Multidisciplinary management of carcinoma of the thyroid.

artículo científico publicado en 1980

Multiple Myeloma Incidence and Mortality around the Globe; Interrelations between Health Access and Quality, Economic Resources, and Patient Empowerment

scientific article published on 25 April 2020

Multiple myeloma: what's new.

artículo científico publicado en 2001

Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients

artículo científico publicado en 1980

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

artículo científico publicado en 2008

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

artículo científico publicado en 2003

Myeloma therapy: 25 years forward--immune modulation then and now

artículo científico publicado en 2008

Myelomonocytic antigen positive multiple myeloma

scientific article published on 01 February 1989

Myelomonocytic myeloma cell line (LB 84-1).

artículo científico publicado en 1989

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

artículo científico publicado en 2017

New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals

artículo científico publicado en 2005

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

artículo científico publicado en 2014

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.

artículo científico publicado en 2017

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

scientific article published on 19 November 2018

Observational study of multiple myeloma in Latin America.

artículo científico publicado en 2016

Oncology nurses take the lead in providing novel therapy guidelines for multiple myeloma

scientific article published on 01 June 2008

Osteonecrosis of the jaw and bisphosphonates

artículo científico publicado en 2005

Patient preferences for interferon alfa in multiple myeloma

artículo científico publicado en 1997

Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma

artículo científico publicado en 2009

Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211.

artículo científico publicado en 2015

Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome

artículo científico publicado en 1985

Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).

artículo científico publicado en 2009

Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study

artículo científico publicado el 1 de diciembre de 1977

Phenotypic analysis of human myeloma cell lines.

artículo científico publicado en 1989

Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226

scientific article published on 01 March 1988

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

artículo científico publicado en 2012

Polyamines as markers of response and disease activity in cancer chemotherapy ⬇️

artículo científico publicado el 1 de enero de 1977

Polyamines as predictors of success and failure in cancer chemotherapy

artículo científico publicado en 1975

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network

artículo científico publicado en 2019

Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma.

artículo científico

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

artículo científico publicado en 2007

Prognostic factors and staging in multiple myeloma: a reappraisal

scientific article published on 01 January 1986

Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study

artículo científico publicado en 1990

Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma

artículo científico publicado en 2018

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

artículo científico publicado en 1978

Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy

artículo científico

Reappraisal of plateau phase in myeloma

scientific article published on 01 July 1980

Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.

artículo científico publicado en 2018

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group

artículo científico publicado en 2018

Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma

artículo científico publicado en 1981

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

artículo científico publicado en 2010

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

artículo científico publicado en 2013

Reversal of drug-resistance in multiple myeloma with verapamil.

artículo científico publicado en 1988

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

artículo científico publicado en 2015

Risk of multiple myeloma in a case-spouse study

artículo científico publicado en 2015

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study ⬇️

artículo científico publicado el 29 de julio de 2011

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

artículo científico publicado en 2017

Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma

artículo científico publicado en 2018

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

artículo científico publicado en 2015

Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival

scientific article published on May 2010

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

artículo científico publicado en 2016

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

scientific article published on 01 April 2018

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders ⬇️

artículo científico publicado el 1 de enero de 1984

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging ⬇️

artículo científico publicado el 1 de noviembre de 1983

Spontaneous secretion of tumor necrosis factor-beta by human myeloma cell lines

artículo científico publicado en 1989

Staging and kinetics of multiple myeloma

artículo científico publicado en 1982

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

artículo científico publicado en 2006

Superiority of magnetic resonance imaging over conventional radiographs in multiple myeloma.

artículo científico publicado en 2009

Survival and years of life lost in different age cohorts of patients with multiple myeloma

artículo científico publicado en 2010

Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries

artículo científico publicado en 2019

Synthesis and metabolism of Bence Jones protein and calculation of tumour burden in patients with Bence Jones myeloma

artículo científico publicado en 1981

T-cell antigen-positive multiple myeloma

artículo científico publicado en 1990

The current status and future prospects of treatment for multiple myeloma

artículo científico publicado en 1982

The epidemiology of multiple myeloma

artículo científico publicado en 2001

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network ⬇️

artículo científico publicado el 28 de junio de 2013

The relationship between autoimmune states and B cell proliferations

artículo científico publicado en 1989

The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system

artículo científico publicado en 2006

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

artículo científico publicado en 2008

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

scientific article published on 02 September 2010

The utility of newer imaging techniques as predictors of clinical outcomes in multiple myeloma

artículo científico publicado en 2014

Therapeutic implications of myeloma staging

artículo científico publicado en 1989

Therapeutic strategies in multiple myeloma

artículo científico publicado el 1 de enero de 1980

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

artículo científico publicado en 2006

Total cost comparison in relapsed/refractory multiple myeloma

artículo científico publicado en 2013

Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry

scientific article published on 14 October 2019

Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry

artículo científico publicado en 2018

Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics

artículo científico publicado el 1 de mayo de 1977

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

scientific article published on 21 March 2016

Treatment of myeloma--are we making progress?

artículo científico publicado en 2008

Tumor growth stimulation in vitro by interferons

artículo científico publicado en 1983

Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement

scientific article published on 01 April 2007

Whole-body (18)F-FDG PET identifies high-risk myeloma.

artículo científico publicado en 2002

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.

artículo científico publicado en 2017

[An attempt at identification of osteoclastic activation factors implicated in myeloma]

artículo científico publicado en 1988

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda